Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve 1. To consider and approve the Unaudited Standalone and Unaudited Consolidated Financial Results of the Company for the Quarter ended June 30, 2026 along with the Limited Review of Auditors thereon.\r\n\r\n2. To authorize Mr. Punitkumar Rasadia, Chairman & Managing Director and/or Mr. Meet Vachhani, Whole Time Director of the Company, for entering into a share swap arrangement with the shareholders of Apiqo Organics Private Limited ('AOPL') and Bizotic LifeScience Private Limited ('BLPL') to acquire 32.52% shareholding in AOPL and 43.33% shareholding in BLPL, to make both these entities as wholly owned subsidiaries, in lieu of issuance and allotment of the fresh equity shares of the Company on a preferential basis for consideration other than cash, to such selling shareholders.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.\r\n